Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Assets (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Assets for 5 consecutive years, with $69.4 million as the latest value for Q4 2025.

  • Quarterly Assets fell 45.33% to $69.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $69.4 million through Dec 2025, down 45.33% year-over-year, with the annual reading at $69.4 million for FY2025, 45.33% down from the prior year.
  • Assets for Q4 2025 was $69.4 million at Werewolf Therapeutics, down from $79.6 million in the prior quarter.
  • The five-year high for Assets was $195.1 million in Q1 2023, with the low at $69.4 million in Q4 2025.
  • Average Assets over 5 years is $149.4 million, with a median of $168.5 million recorded in 2022.
  • The sharpest move saw Assets soared 84.08% in 2022, then tumbled 45.33% in 2025.
  • Over 5 years, Assets stood at $179.2 million in 2021, then dropped by 10.6% to $160.2 million in 2022, then rose by 9.1% to $174.8 million in 2023, then fell by 27.4% to $126.9 million in 2024, then crashed by 45.33% to $69.4 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $69.4 million, $79.6 million, and $92.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.